NATALIE SEAY: Open Payments
NPI 1003387234 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 59 payments from 18 companies in 2025. Trend: 2023 $1,915 · 2024 $2,238 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $185 |
| ABBVIE INC. | 11 | $168 |
| Ipsen Biopharmaceuticals, Inc | 5 | $134 |
| Janssen Biotech, Inc. | 5 | $108 |
| QOL Medical, LLC | 4 | $94 |
| GENZYME CORPORATION | 3 | $68 |
| Ardelyx, Inc. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| PFIZER INC. | 2 | $51 |
Products named: XIFAXAN, LINZESS, IQIRVO, TREMFYA, Sucraid, DUPIXENT, IBSRELA, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
